Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 289

The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.

Foundations of gastrointestinal-based drug delivery and future developments

Open access
Chu, Jacqueline N., Traverso, Giovanni·2022·Nature Reviews Gastroenterology & Hepatology

Abstract

Gastrointestinal-based drug delivery is considered the preferred mode of drug administration owing to its convenience for patients, which improves adherence. However, unique characteristics of the gastrointestinal tract (such as the digestive environment and constraints on transport across the gastrointestinal mucosa) limit the absorption of drugs. As a result, many medications, in particular biologics, still exist only or predominantly in injectable form. In this Review, we examine the fundamentals of gastrointestinal drug delivery to inform clinicians and pharmaceutical scientists. We discuss general principles, including the challenges that need to be overcome for successful drug formulation, and describe the unique features to consider for each gastrointestinal compartment when designing drug formulations for topical and systemic applications. We then discuss emerging technologies that seek to address remaining obstacles to successful gastrointestinal-based drug delivery. In this Review, Chu and Traverso provide an overview of gastrointestinal-based drug delivery, discussing conventional delivery methods and challenges posed by the gastrointestinal tract as a drug delivery environment, as well as emerging technologies. Unique characteristics of the gastrointestinal tract must be taken into account when designing drugs for oral or rectal administration. Physical boundary conditions include swallowing constraints, lumen size, drug residence and transit times, mucin and epithelial turnover, and wall thickness of the gastrointestinal tract. Differences in boundary conditions between anatomical compartments, as well as variation in absorptive area, pH, cells and transporters, permeability, and bacterial population, are both a challenge and an opportunity for targeted drug delivery. Strategies to enable gastrointestinal delivery of biologics include non-physical technologies that stabilize the drug and/or enhance absorption, and physical technologies that use a device for mucosal penetration. Strategies to achieve ultra-long (>24 h) systemic drug delivery include gastrointestinal resident systems and implants. Additional emerging technologies in gastrointestinal drug delivery include high-throughput systems for drug development, electronics and closed-loop systems, novel triggers, microorganism-based and cell-based therapeutics, and new technologies to maximize the endoscope. Unique characteristics of the gastrointestinal tract must be taken into account when designing drugs for oral or rectal administration. Physical boundary conditions include swallowing constraints, lumen size, drug residence and transit times, mucin and epithelial turnover, and wall thickness of the gastrointestinal tract. Differences in boundary conditions between anatomical compartments, as well as variation in absorptive area, pH, cells and transporters, permeability, and bacterial population, are both a challenge and an opportunity for targeted drug delivery. Strategies to enable gastrointestinal delivery of biologics include non-physical technologies that stabilize the drug and/or enhance absorption, and physical technologies that use a device for mucosal penetration. Strategies to achieve ultra-long (>24 h) systemic drug delivery include gastrointestinal resident systems and implants. Additional emerging technologies in gastrointestinal drug delivery include high-throughput systems for drug development, electronics and closed-loop systems, novel triggers, microorganism-based and cell-based therapeutics, and new technologies to maximize the endoscope.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41575-021-00539-w

Cites

193 of 193 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 193 references

Cited by

See all 289

Metadata

Authors
Chu, J. N., & Traverso, G.
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2021-11-16
Volume
19
Issue
4
Pages
219-238
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W3213425375
Cited by
289
References
193
FWCI
3.58
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Foundations of gastrointestinal-based drug delivery and future developments. https://app.cochat.ai/papers/10.1038/s41575-021-00539-w
The paper
Chu, J. N., & Traverso, G. (2022). Foundations of gastrointestinal-based drug delivery and future developments. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-021-00539-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.